News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Avecho.
RELATED STOCKHEAD STORIES
Health & Biotech
Check Up: Moderna posts crazy cancer vaccine results, says melanoma recurrence down by almost half
Health & Biotech
Weed Week: Budding Asian pot market could be flying at US$120m by 2026
News
Closing Bell: No surprise here — Aussie economy set to grow at a snails pace next year
News
Lunch Wrap: Grinch hands out speeding tickets and puts dampener on ASX this Christmas
News
Top 10 at 10: Meteoric lives up to its name with 220% gain in 3 days
Explainers
ASX Cannabis Stocks Guide 2022/23: Here’s everything you need to know
Health & Biotech
Weed Week: Greens push hard to legalise cannabis and Cronos has 3% of Aussie GPs on its platform already
Health & Biotech
ASX Health Stocks: Polynovo leaps 12pc after coming out of trading halt, gets FDA approval
Health & Biotech
Weed Week: Will the US Senate pass the MORE act, and Swiss cannabis wellness spas are a thing
Experts
ScoPo’s Powerplays: Which ASX health stocks are winners from the Federal Budget?
Health & Biotech
Check Up: More clinical trials and FDA funding boost. Is this the end of biotech’s woes?
Health & Biotech
ASX Health Stocks: CBD gel could become cornerstone therapy for hand arthritis, says Avecho
News
Weed Week: New Yorkers with cannabis convictions first in line for retail licences, CBX Stock Exchange launches
Health & Biotech
ASX Health Stocks: Cannabis biotech Avecho begins dosing patients in CBD gel study to treat osteoarthritis
News
Rise and Shine: What you need to know before the ASX opens
News
ASX Small Cap Lunch Wrap: Who’s on trend again?
Health & Biotech
